EUVIMEDEUVIMED entdecken
Open Access

GLP-1 Receptor Agonist Use Is Associated With Lower Risk of Intracranial Aneurysm Rupture and Rupture Severity

Huanwen Chen iD, Matthew K McIntyre iD, Jay Kakadiya iD, Pranjal Rai iD, Muhammed Amir Essibayi iD, Hamza A Salim iD, Ahmed Y Azzam iD, Shahrzad Latifikhereshky, Vivek S Yedavalli iD, David J Altschul iD, Adam A Dmytriw iD, Marco Colasurdo iD und 3 weitere

Stroke · 2026-07 · 57 (7) · 1979-1990

DOI: 10.1161/strokeaha.126.055692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2026-07. Verfasst von Huanwen Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology (H.C.), University of Maryland Medical Center, Baltimore. Hauptthemen laut MEDLINE: Intracranial Aneurysm, Glucagon-Like Peptide-1 Receptor Agonists, Aneurysm, Ruptured. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Unruptured intracranial aneurysms (UIAs) affect up to 5% of the population, and rupture can lead to devastating subarachnoid hemorrhage. GLP-1RAs (glucagon-like peptide-1 receptor agonists) have anti-inflammatory and vasculoprotective effects, but their impact on aneurysm stability and subarachnoid hemorrhage outcomes is unexplored. This study evaluated whether GLP-1RA use is associated with reduced rupture risk and attenuated severity in the event of a rupture. METHODS: We conducted a retrospective cohort study using the TriNetX US Collaborative Network (2016–2024). Cohort 1 included patients with newly diagnosed, untreated UIA; cohort 2 included those who suffered aneurysm rupture. GLP-1RA exposure was defined as use before or within 3 months of UIA diagnosis (cohort 1) or before rupture (cohort 2). The primary outcome was aneurysm rupture risk in cohort 1. Secondary outcomes include presentation severity, vasospasm, and mortality in cohort 2. Propensity score matching balanced demographics, comorbidities, and medications. RESULTS: After propensity score match, cohort 1 of patients with untreated UIA included 8088 GLP-1RA users and 8088 nonusers. GLP-1RA use was associated with significantly lower probabilities of aneurysm rupture at 1-year (0.65% versus 1.51%; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intracranial AneurysmGlucagon-Like Peptide-1 Receptor AgonistsAneurysm, RupturedHumansFemaleMaleRetrospective StudiesMiddle AgedAgedSubarachnoid HemorrhageCohort StudiesSeverity of Illness IndexRisk Factors

Stichwörter der Autor:innen

endothelial cellsglycemic controlintracranial aneurysmsubarachnoid hemorrhagevasoconstriction

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Neurology (H.C.), University of Maryland Medical Center, Baltimore.
  • Department of Neurosurgery (H.C., D.G.), University of Maryland Medical Center, Baltimore.
  • Department of Neurosurgery (M.K.M.), Oregon Health and Science University, Portland.
  • Department of Neuroradiology (J.K., H.A.S., A.Y.A., D.A.L.), Rockefeller Neuroscience Institute, West Virginia University, Morgantown.
  • Department of Radiology, Mayo Clinic, Rochester, MN (P.R.).
  • Department of Neurological Surgery, Montefiore Medical Center, University Hospital for Albert Einstein College of Medicine, Bronx, NY (M.A.E., A.Y.A., D.J.A.).

ORCID-Profile: Huanwen Chen, Matthew K McIntyre, Jay Kakadiya, Pranjal Rai, Muhammed Amir Essibayi, Hamza A Salim, Ahmed Y Azzam, Vivek S Yedavalli, David J Altschul, Adam A Dmytriw, Marco Colasurdo, Ajay Malhotra, Dheeraj Gandhi, Dhairya A Lakhani

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Chen, H., McIntyre, M. K., Kakadiya, J., Rai, P., Essibayi, M. A., Salim, H. A., Azzam, A. Y., Latifikhereshky, S., Yedavalli, V. S., Altschul, D. J., Dmytriw, A. A., Colasurdo, M., Malhotra, A., Gandhi, D., & Lakhani, D. A. (2026). GLP-1 Receptor Agonist Use Is Associated With Lower Risk of Intracranial Aneurysm Rupture and Rupture Severity. Stroke, 57(7), 1979-1990. https://doi.org/10.1161/strokeaha.126.055692

Vancouver

Chen H, McIntyre MK, Kakadiya J, Rai P, Essibayi MA, Salim HA, et al. GLP-1 Receptor Agonist Use Is Associated With Lower Risk of Intracranial Aneurysm Rupture and Rupture Severity. Stroke. 2026;57(7):1979-1990. doi:10.1161/strokeaha.126.055692

BibTeX
@article{Chen2026,
  author = {Chen, Huanwen and McIntyre, Matthew K and Kakadiya, Jay and Rai, Pranjal and Essibayi, Muhammed Amir and Salim, Hamza A and Azzam, Ahmed Y and Latifikhereshky, Shahrzad and Yedavalli, Vivek S and Altschul, David J and Dmytriw, Adam A and Colasurdo, Marco and Malhotra, Ajay and Gandhi, Dheeraj and Lakhani, Dhairya A},
  title = {GLP-1 Receptor Agonist Use Is Associated With Lower Risk of Intracranial Aneurysm Rupture and Rupture Severity},
  journal = {Stroke},
  year = {2026},
  volume = {57},
  number = {7},
  pages = {1979--1990},
  doi = {10.1161/strokeaha.126.055692}
}
Kostenlos starten →